Comparison of peripheral blood markers in predicting the occurrence of immune-related adverse events in patients with metastatic genitourinary cancer treated with cabozantinib + nivolumab +/- ...
The burden of CKD is on the rise worldwide as the global population ages. Long considered universally progressive, recent studies suggest that CKD may regress with advancing age. Such findings may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback